1. Viano, I.et al. (1989) Positive interaction between interferon and bleomycinin vitro and in animal experimental models.Anticancer Res. 9, 673–8.
2. Sklarin, N.T.et al. (1988) Augmentation of activity of cis-diamminedichloroplatinum (II) and mitomycin C by interferon in human malignant mesothelioma xenografts in nude mice.Cancer Res. 48, 64–7.
3. Borden, E.C. and Hawkings, M.J. (1986) Biologic response modifiers as adjuvents to other therapeutic modalities.Semin. Oncol. 13, 144–52.
4. Van Hoff, D.D.et al. (1986) Rationale for and conduct of a phase I clinical trial with interferon α-2b plus doxorubin.Semin. Oncol. 13, 72–7.
5. Elias, L. and Crissman, H.A. (1988) Interferon effects upon the adenocarcinoma 38 and HL-60 cell lines: antiproliferative responses and synergistic interactions with halogenated pyrimidine antimetabolites.Cancer Res. 48, 4868–73.